ReviewGalen medical journal2024
Emerging Diagnostic Modalities in Oral Cancer Detection and Management.
Review in Galen medical journal, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Oral cancer remains a significant global health concern, yet it is often detected at an advanced stage. The limitations of traditional diagnostic techniques have prompted increased research efforts towards the development of more efficient and early detection methods. Recent advancements in oral cancer diagnosis include the use of salivary biomarkers, optical imaging, liquid biopsy, advanced imaging, and AI algorithms. These non-invasive and painless sampling methods have shown high sensitivity and specificity, particularly in the case of salivary biomarkers. Clinical trials and cooperation are necessary to demonstrate the effectiveness of these technologies and gain approval from relevant authorities and acceptance among clinicians. This review highlights the potential of these new modalities in transforming the approach to oral cancer diagnosis, leading to early detection, accurate diagnosis, and quality treatment for patients, ultimately reducing the global burden of this disease.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.